Usefulness of Myocardial Deformation Indices in Preventing Cardiotoxicity in Breast Cancer Patients.
作者信息
Melo Marcelo Dantas Tavares de, Salemi Vera Maria Cury
机构信息
Instituto do Coração (InCor) do Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, SP - Brazil.
出版信息
Arq Bras Cardiol. 2019 Jan;112(1):57-58. doi: 10.5935/abc.20190009.
Abstract
摘要
相似文献
1
Usefulness of Myocardial Deformation Indices in Preventing Cardiotoxicity in Breast Cancer Patients.
Arq Bras Cardiol. 2019 Jan;112(1):57-58. doi: 10.5935/abc.20190009.
2
Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity.
J Am Soc Echocardiogr. 2013 May;26(5):493-8. doi: 10.1016/j.echo.2013.02.008. Epub 2013 Apr 3.
3
Cardiac magnetic resonance imaging-based myocardial strain study for evaluation of cardiotoxicity in breast cancer patients treated with trastuzumab: A pilot study to evaluate the feasibility of the method.
Cardiol J. 2016;23(3):270-80. doi: 10.5603/CJ.a2016.0023. Epub 2016 May 13.
4
[Possibilities of estimation of breast cancer targeted therapy cardiotoxicity in routine clinical practice].
Kardiologiia. 2019 Apr 13;59(3S):10-15. doi: 10.18087/cardio.2550.
5
Analysis of HER2 and HER4 in human myocardium to clarify the cardiotoxicity of trastuzumab (Herceptin).
Breast Cancer Res Treat. 2003 Nov;82(1):23-8. doi: 10.1023/b:brea.0000003916.39959.73.
6
Cardiotoxicity and Cardiac Monitoring During Adjuvant Trastuzumab in Daily Dutch Practice: A Study of the Southeast Netherlands Breast Cancer Consortium.
Oncologist. 2016 May;21(5):555-62. doi: 10.1634/theoncologist.2015-0230. Epub 2016 Mar 23.
7
Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer.
Intern Emerg Med. 2016 Feb;11(1):123-40. doi: 10.1007/s11739-015-1362-x. Epub 2015 Dec 28.
8
Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
JACC Cardiovasc Imaging. 2018 Aug;11(8):1084-1093. doi: 10.1016/j.jcmg.2018.06.005.
9
Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.
Semin Oncol. 2001 Oct;28(5 Suppl 16):18-26. doi: 10.1016/s0093-7754(01)90278-7.
10
Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity.
Rev Port Cardiol. 2017 Jan;36(1):9-15. doi: 10.1016/j.repc.2016.06.009. Epub 2016 Dec 7.
本文引用的文献
1
Left Ventricular Regional Wall Motion Abnormality is a Strong Predictor of Cardiotoxicity in Breast Cancer Patients Undergoing Chemotherapy.
Arq Bras Cardiol. 2019 Jan;112(1):50-56. doi: 10.5935/abc.20180220. Epub 2018 Dec 13.
2
Adding Speckle-Tracking Echocardiography to Visual Assessment of Systolic Wall Motion Abnormalities Improves the Detection of Myocardial Infarction.
J Am Soc Echocardiogr. 2019 Jan;32(1):65-73. doi: 10.1016/j.echo.2018.09.007. Epub 2018 Oct 17.
3
Long-term heart-specific mortality among 347 476 breast cancer patients treated with radiotherapy or chemotherapy: a registry-based cohort study.
Eur Heart J. 2018 Nov 14;39(43):3896-3903. doi: 10.1093/eurheartj/ehy167.
4
Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
JACC Cardiovasc Imaging. 2018 Aug;11(8):1059-1068. doi: 10.1016/j.jcmg.2018.01.015. Epub 2018 Mar 14.
5
Abnormal Motion Patterns of the Interventricular Septum.
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1281-1284. doi: 10.1016/j.jcmg.2017.06.014.
6
Impact of persistent left ventricular regional wall motion abnormalities in childhood cancer survivors after anthracycline therapy: Assessment of global left ventricular myocardial performance by 3D speckle-tracking echocardiography.
J Cardiol. 2017 Oct;70(4):396-401. doi: 10.1016/j.jjcc.2016.12.015. Epub 2017 Feb 24.
7
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Eur Heart J. 2016 Sep 21;37(36):2768-2801. doi: 10.1093/eurheartj/ehw211. Epub 2016 Aug 26.
8
Cancer treatment and survivorship statistics, 2016.
CA Cancer J Clin. 2016 Jul;66(4):271-89. doi: 10.3322/caac.21349. Epub 2016 Jun 2.
9
Cardiovascular disease after cancer therapy.
EJC Suppl. 2014 Jun;12(1):18-28. doi: 10.1016/j.ejcsup.2014.03.002. Epub 2014 May 29.
10
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
Zotero 插件